PharmChem (United States)

Small businesses, startup companies and virtual companies must rely heavily on outsourcing to meet time frames and obtain the necessary technical skills to be successful. In this chapter an Outsourcing Process is presented which would provide the most efficient and effective approach to outsourcing. Also provided are procedural flow charts and the documentation required for the process.

This chapter discusses relevant sections of the Code of Federal Regulations which may apply to forensic chemistry, such as the GMPs and GLPs, which contain work processes such as method development, reference standards, sample preparation, system suitability, calculations, data reporting, training, and standard operating procedures that can be applied to the practice of forensic chemistry.

ChemInformVolume 36, Issue 18 Isocyclic Compounds Discovery of Potent Thiosemicarbazone Inhibitors (V) of Rhodesain and Cruzain. Naoaki Fujii, Naoaki Fujii Dep. Pharm. Chem., Sch. Pharm., Univ. Calif., San Francisco, CA 94143, USASearch for more papers by this authorJeremy P. Mallari, Jeremy P. Mallari Dep. Pharm. Chem., Sch. Pharm., Univ. Calif., San Francisco, CA 94143, USASearch for more papers by this authorElizabeth J. Hansell, Elizabeth J. Hansell Dep. Pharm. Chem., Sch. Pharm., Univ. Calif., San Francisco, CA 94143, USASearch for more papers by this authorZ. Mackey, Z. Mackey Dep. Pharm. Chem., Sch. Pharm., Univ. Calif., San Francisco, CA 94143, USASearch for more papers by this authorPatricia Doyle, Patricia Doyle Dep. Pharm. Chem., Sch. Pharm., Univ. Calif., San Francisco, CA 94143, USASearch for more papers by this authorY. M. Zhou, Y. M. Zhou Dep. Pharm. Chem., Sch. Pharm., Univ. Calif., San Francisco, CA 94143, USASearch for more papers by this authorJiri Gut, Jiri Gut Dep. Pharm. Chem., Sch. Pharm., Univ. Calif., San Francisco, CA 94143, USASearch for more papers by this authorPhilip J. Rosenthal, Philip J. Rosenthal Dep. Pharm. Chem., Sch. Pharm., Univ. Calif., San Francisco, CA 94143, USASearch for more papers by this authorJames H. McKerrow, James H. McKerrow Dep. Pharm. Chem., Sch. Pharm., Univ. Calif., San Francisco, CA 94143, USASearch for more papers by this authorR. Kiplin Guy, R. Kiplin Guy Dep. Pharm. Chem., Sch. Pharm., Univ. Calif., San Francisco, CA 94143, USASearch for more papers by this author Naoaki Fujii, Naoaki Fujii Dep. Pharm. Chem., Sch. Pharm., Univ. Calif., San Francisco, CA 94143, USASearch for more papers by this authorJeremy P. Mallari, Jeremy P. Mallari Dep. Pharm. Chem., Sch. Pharm., Univ. Calif., San Francisco, CA 94143, USASearch for more papers by this authorElizabeth J. Hansell, Elizabeth J. Hansell Dep. Pharm. Chem., Sch. Pharm., Univ. Calif., San Francisco, CA 94143, USASearch for more papers by this authorZ. Mackey, Z. Mackey Dep. Pharm. Chem., Sch. Pharm., Univ. Calif., San Francisco, CA 94143, USASearch for more papers by this authorPatricia Doyle, Patricia Doyle Dep. Pharm. Chem., Sch. Pharm., Univ. Calif., San Francisco, CA 94143, USASearch for more papers by this authorY. M. Zhou, Y. M. Zhou Dep. Pharm. Chem., Sch. Pharm., Univ. Calif., San Francisco, CA 94143, USASearch for more papers by this authorJiri Gut, Jiri Gut Dep. Pharm. Chem., Sch. Pharm., Univ. Calif., San Francisco, CA 94143, USASearch for more papers by this authorPhilip J. Rosenthal, Philip J. Rosenthal Dep. Pharm. Chem., Sch. Pharm., Univ. Calif., San Francisco, CA 94143, USASearch for more papers by this authorJames H. McKerrow, James H. McKerrow Dep. Pharm. Chem., Sch. Pharm., Univ. Calif., San Francisco, CA 94143, USASearch for more papers by this authorR. Kiplin Guy, R. Kiplin Guy Dep. Pharm. Chem., Sch. Pharm., Univ. Calif., San Francisco, CA 94143, USASearch for more papers by this author First published: 06 April 2005 https://doi.org/10.1002/chin.200518079Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article. Volume36, Issue18May 3, 2005 RelatedInformation

A critical barrier to entry into structure-based virtual screening is the lack of a suitable, easy to access database of purchasable compounds. We have therefore prepared a library of 727,842 molecules, each with 3D structure, using catalogs of compounds from vendors (the size of this library continues to grow). The molecules have been assigned biologically relevant protonation states and are annotated with properties such as molecular weight, calculated LogP, and number of rotatable bonds. Each molecule in the library contains vendor and purchasing information and is ready for docking using a number of popular docking programs. Within certain limits, the molecules are prepared in multiple protonation states and multiple tautomeric forms. In one format, multiple conformations are available for the molecules. This database is available for free download (http://zinc.docking.org) in several common file formats including SMILES, mol2, 3D SDF, and DOCK flexibase format. A Web-based query tool incorporating a molecular drawing interface enables the database to be searched and browsed and subsets to be created. Users can process their own molecules by uploading them to a server. Our hope is that this database will bring virtual screening libraries to a wide community of structural biologists and medicinal chemists.

Abstract For Abstract see ChemInform Abstract in Full Text.

After incubation of delta9-tetrahydrocannabivarin with human hepatocytes, a major metabolic product was detected by gas chromatography-mass spectrometry that showed identical retention time and mass spectrum to the synthetic 11-nor-delta9-tetrahydrocannabivarin-9-carboxylic acid (11-nor-delta9-THCV-9-COOH). Analysis of human urine specimens from marijuana users and plasma samples from Marinol users showed that 11-nor-delta9-THCV-9-COOH was only present in urine specimens of marijuana users. These results supported the conclusion that identification of 11-nor-delta9-THCV-9-COOH in a donor's urine specimen indicates the use or ingestion of cannabis-related product(s) and would not explain the sole use of Marinol.

Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.

Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.

Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.

Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.